Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

WavelinQ 4F EndoAVF System

K-Number: K182796 · 2019-02-06

Decision Date2019-02-06
Product CodePQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

WavelinQ 4F EndoAVF System is a medical device manufactured by C.R. Bard, Inc.. It received FDA 510(k) clearance on 2019-02-06 under approval number K182796. The device is classified under product code PQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the WavelinQ 4F EndoAVF System?

WavelinQ 4F EndoAVF System is a medical device that received FDA 510(k) clearance on 2019-02-06. It is manufactured by C.R. Bard, Inc.. The 510(k) number is K182796.

When was WavelinQ 4F EndoAVF System approved by the FDA?

WavelinQ 4F EndoAVF System received FDA 510(k) clearance on 2019-02-06, under approval number K182796.

What company makes WavelinQ 4F EndoAVF System?

WavelinQ 4F EndoAVF System is manufactured by C.R. Bard, Inc..

What is the FDA product code for WavelinQ 4F EndoAVF System?

The FDA product code for WavelinQ 4F EndoAVF System is PQK.

Related Clinical Trials

Other Devices by C.R. Bard, Inc.

View all 67 devices →

Related Devices (Code: PQK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.